We first examined publicly available mRNA expression data from a study in which immunocompetent mice were inoculated with bilateral s.c. murine AB1-HA mesothelioma tumors and treated with an anti–CTLA-4 antibody (42). This evidence concerns the gene CTLA4 and mesothelioma.